MMP2 and non-small cell lung carcinoma: Additionally, miR-3157-3p is transported from NSCLC cells to vascular endothelial cells through exosomes, targeting the vascular endothelial growth factor (VEGF)/matrix metalloproteinase 2 (MMP2)/MMP9 pathway to enhance the formation of new blood vessels (Ma et al., 2021).